ATE119894T1 - Herstellung der form 1 von ranitidin hydrochlorid. - Google Patents

Herstellung der form 1 von ranitidin hydrochlorid.

Info

Publication number
ATE119894T1
ATE119894T1 AT93304182T AT93304182T ATE119894T1 AT E119894 T1 ATE119894 T1 AT E119894T1 AT 93304182 T AT93304182 T AT 93304182T AT 93304182 T AT93304182 T AT 93304182T AT E119894 T1 ATE119894 T1 AT E119894T1
Authority
AT
Austria
Prior art keywords
ranitidine hydrochloride
preparation
prepared
volume
solution
Prior art date
Application number
AT93304182T
Other languages
English (en)
Inventor
Teng-Ko Ngooi
Casimir Antczak
Jeffrey David Mcgolrick
James Lorne Anthony Tindall
Original Assignee
Torcan Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torcan Chemical Ltd filed Critical Torcan Chemical Ltd
Application granted granted Critical
Publication of ATE119894T1 publication Critical patent/ATE119894T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT93304182T 1993-04-01 1993-05-28 Herstellung der form 1 von ranitidin hydrochlorid. ATE119894T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US08/041,354 US5338871A (en) 1991-12-20 1993-04-01 Preparation of form 1 ranitidine hydrochloride
EP93304182A EP0626381B1 (de) 1993-04-01 1993-05-28 Herstellung der Form 1 von Ranitidin Hydrochlorid
CA002099530A CA2099530C (en) 1993-04-01 1993-07-02 Preparation of form 1 ranitidine hydrochloride
AU41794/93A AU674006B2 (en) 1993-04-01 1993-07-06 Preparation of form 1 ranitidine hydrochloride
HU9301980A HU214334B (hu) 1993-04-01 1993-07-08 Eljárás ranitidin-hidroklorid 1 kristályformájának előállítására
ZA934995A ZA934995B (en) 1993-04-01 1993-07-12 Preparation of form 1 ranitidine hydrochloride
NZ260551A NZ260551A (en) 1993-04-01 1994-05-18 Preparation of form 1 ranitidine hcl crystals

Publications (1)

Publication Number Publication Date
ATE119894T1 true ATE119894T1 (de) 1995-04-15

Family

ID=27560579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93304182T ATE119894T1 (de) 1993-04-01 1993-05-28 Herstellung der form 1 von ranitidin hydrochlorid.

Country Status (11)

Country Link
US (1) US5338871A (de)
EP (1) EP0626381B1 (de)
AT (1) ATE119894T1 (de)
AU (1) AU674006B2 (de)
CA (1) CA2099530C (de)
DE (1) DE69300088T2 (de)
DK (1) DK0626381T3 (de)
ES (1) ES2069446T3 (de)
HU (1) HU214334B (de)
NZ (1) NZ260551A (de)
ZA (1) ZA934995B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
IN181699B (de) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
DE69504156T2 (de) * 1994-06-24 1998-12-24 Ranbaxy Lab Ltd Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1
AU1671295A (en) * 1994-12-19 1996-07-10 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
ES2331937T3 (es) 1996-06-13 2010-01-20 Sumitomo Chemical Company, Limited Derivados de piperidina como intermediarios para la preparacion de paroxetina y procedimiento de preparacion de los mismos.
US20020151729A1 (en) * 1997-02-26 2002-10-17 Cheng Wen J. Novel process for the preparation of form 1 ranitidine hydrochloride
IE990387A1 (en) * 1998-06-17 2000-12-13 Russinsky Ltd A ranitidine base water adduct
IT1317858B1 (it) * 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
DE102006015960A1 (de) * 2006-04-04 2007-10-11 Qiagen Gmbh Gemisch reversibel inhibierter Enzyme
WO2011160037A2 (en) * 2010-06-17 2011-12-22 Dr. Reddy's Laboratories Ltd. Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride
EP2929884A1 (de) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmazeutische kombinationen aus dabigatran und h2-rezeptor-antagonisten
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181084A (en) * 1980-01-08 1985-01-15 Glaxo Group Limited Process for the preparation of a furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
DE3211127C1 (de) * 1982-03-26 1983-08-11 Degussa Ag, 6000 Frankfurt Verfahren zur Gewinnung von S-(Carboxymethyl)-(R)-cystein und S-(Carboxymethyl)-(S)-cystein
US4613688A (en) * 1982-04-02 1986-09-23 Showa Denko Kabushiki Kaisha Optical resolution process for DL-cysteine
JPH0730064B2 (ja) * 1989-08-17 1995-04-05 協和醗酵工業株式会社 フラン誘導体

Also Published As

Publication number Publication date
US5338871A (en) 1994-08-16
DK0626381T3 (da) 1995-10-02
AU4179493A (en) 1995-01-27
NZ260551A (en) 1995-02-24
HU214334B (hu) 1998-03-02
EP0626381B1 (de) 1995-03-15
DE69300088D1 (de) 1995-04-20
CA2099530A1 (en) 1995-01-03
CA2099530C (en) 2002-10-08
ZA934995B (en) 1994-02-11
HU9301980D0 (en) 1993-09-28
ES2069446T3 (es) 1995-05-01
DE69300088T2 (de) 1995-08-31
AU674006B2 (en) 1996-12-05
EP0626381A1 (de) 1994-11-30
HUT68736A (en) 1995-04-27

Similar Documents

Publication Publication Date Title
DE69300088D1 (de) Herstellung der Form 1 von Ranitidin Hydrochlorid.
DE3852931D1 (de) Flüssigkristalline Cyclopropyl-alkyl- oder -alkenyl-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssig-kristallinen Mischungen.
BR1100445A (pt) Derivados imino cìclicos, composições farmacêuticas contendo estes compostos e processo para sua preparação
CA2067877A1 (en) Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
CA2157117A1 (en) Spirocyclic Piperidine Derivatives
FR2636948A1 (fr) N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
KR910009707A (ko) 피소스타그민에 관련된 아미노카보닐카바메이트, 이의 제조방법 및 이의 약제로서의 용도
EP0530369A4 (en) Crystal comprising indolinospirobenzothiopyran derivative and ring-opening isomer thereof
DK0397044T3 (da) Hidtil ukendte arylsulfonamider, lægemidler, der indeholder disse forbindelser, og fremgangsmåder til deres fremstilling
KR910004562A (ko) 신규 아릴피롤 화합물 및 이들의 제조방법
BR8803402A (pt) Poliisocianatos aromaticos,processo para a sua preparacao e utilizacao
TW231289B (en) Preparation of form 1 ranitidine hydrochloride
ES2075262T3 (es) Resinas de poliester insaturado.
DK0500443T3 (da) Phenylethanolamino- og phenylethanolaminomethyltetraliner, fremgangsmåde til deres fremstilling, mellemprodukter til denne fremgangsmåde og farmaceutiske præparater der indeholder dem
ATE126510T1 (de) Herstellung von isochinolinderivaten.
DE3887102T2 (de) Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
JPS6490286A (en) Photochromic composition
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
KR950003281A (ko) 제1형 염산라니티딘의 제조방법
KR890000537A (ko) 폴리우레탄 조성물 및 이의제법
KR890013076A (ko) 이미드 결합을 지닌 화합물의 제조 방법 및 이 화합물을 함유하는 난연제
KR890016101A (ko) 이미드 결합을 지닌 수지의 제조합법 및 그 수지로 이루어진 난연제
NO933465D0 (no) Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling
TH13833A (th) สารประกอบ

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee